Medtronic's next-gen hybrid closed loop system will be the Minimed 780G, designed to help patients enjoy greater freedom and less burdens. Currently, the 780G is being studied in an in-home trial with 350 adult and pediatric patients with type 1 diabetes participating, using the device over a three-month period. The in-home study is estimated to be completed in January of 2020, with the results presented in July, 2020.
What should you expect from the new Medtronic system?
New vertical "modern" look
Automatic correction bolusing
A new algorithm, that according to Medtronic is more accurate and reliable
A function to automatically adjust for missed meals
Adjustable target range, down to 100 mg/dL
Option for remote software updates
Stay tuned for a launch date and other news on the Minimed 780G!